Pharmacokinetics of 9-nitrocamptothecin after single oral administrations in rats

被引：0
|
作者：
Zhang, Chun-Yan [1 ]
Yin, Qi [2 ]
Li, Yu-Zhen [1 ]
Li, Chang-Ling [3 ]
机构：
[1] Department of Pharmacy, People's Hospital, Peking University, Beijing 100044, China
[2] Department of Pharmacy, Beijing Hospital, Beijing 100730, China
[3] Department of Pharmacology, School of Pharmacology, Peking University, Beijing 100083, China
来源：
Chinese Pharmaceutical Journal | 2005年 / 40卷 / 11期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
5
引用
收藏
页码：852 / 854
相关论文
共 50 条
  • [31] Pharmacokinetics of mebudipine, a new calcium antagonist, following single intravenous and oral administrations in rats
    Bohlooli, S
    Keyhanfar, F
    Mahmoudian, M
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2004, 25 (04) : 187 - 191
  • [32] A phase II study of 9-nitrocamptothecin in patients with advanced pancreatic adenocarcinoma
    Manousos M. Konstadoulakis
    Pantelis T. Antonakis
    Basil G. Tsibloulis
    George P. Stathopoulos
    Andreas P. Manouras
    Despoina B. Mylonaki
    Basil X. Golematis
    Cancer Chemotherapy and Pharmacology, 2001, 48 : 417 - 420
  • [33] 9-nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice
    Koshkina, NV
    Kleinerman, ES
    Waldrep, C
    Jia, SF
    Worth, LL
    Gilbert, BE
    Knight, V
    CLINICAL CANCER RESEARCH, 2000, 6 (07) : 2876 - 2880
  • [34] PHARMACOKINETICS OF FK-506, A NOVEL IMMUNOSUPPRESSANT, AFTER INTRAVENOUS AND ORAL ADMINISTRATIONS TO RATS
    TAKADA, K
    USUDA, H
    OHHASHI, M
    YOSHIKAWA, H
    MURANISHI, S
    TANAKA, H
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1991, 14 (01): : 34 - 42
  • [35] A phase II study of 9-nitrocamptothecin in patients with advanced pancreatic adenocarcinoma
    Konstadoulakis, MM
    Antonakis, PT
    Tsiblouis, BG
    Stathopoulos, GP
    Manouras, AP
    Mylonaki, DB
    Golematis, BX
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (05) : 417 - 420
  • [36] Disposition of 9-nitrocamptothecin and its 9-aminocamptothecin metabolite in relation to ABC transporter genotypes
    Zamboni, William C.
    Ramanathan, Ramesh K.
    McLeod, Howard L.
    Mani, Sridhar
    Potter, Douglas M.
    Strychor, Sandra
    Maruca, Lauren J.
    King, Cristi R.
    Jung, Laura L.
    Parise, Robert A.
    Egorin, Merrill J.
    Davis, Todd A.
    Marsh, Sharon
    INVESTIGATIONAL NEW DRUGS, 2006, 24 (05) : 393 - 401
  • [37] Propionate and butyrate esters of camptothecin and 9-nitrocamptothecin as antileukemia prodrugs in vitro
    Han, Z
    Cao, Z
    Chatterjee, D
    Wyche, J
    Pantazis, P
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1999, 62 (04) : 246 - 255
  • [38] A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer
    Verschraegen, CF
    Gupta, F
    Loyer, E
    Kavanagh, JJ
    Kudelka, AP
    Freedman, RS
    Edwards, CL
    Harris, N
    Steger, M
    Steltz, V
    Giovanella, BC
    Stehlin, JS
    ANTI-CANCER DRUGS, 1999, 10 (04) : 375 - 383
  • [39] A study of 9-nitrocamptothecin (RFS-2000) in patients with advanced pancreatic cancer
    Stehlin, JS
    Giovanella, BC
    Natelson, EA
    De Ipolyi, PD
    Coil, D
    Davis, B
    Wolk, D
    Wallace, P
    Trojacek, A
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 14 (05) : 821 - 831
  • [40] Pharmacokinetics of clomipramine and desmethylclomipramine after single-dose intravenous and oral administrations in cats
    Lainesse, C
    Frank, D
    Meucci, V
    Intorre, L
    Soldani, G
    Doucet, M
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2006, 29 (04) : 271 - 278
12345